加载中
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
收盘时
US$8.965
+US$0.075 · +0.84%
盘后
US$8.965
US$0.00 · 0.00%
10月12日 16:10 ET
盘中时间采用ET。市场数据可能有所延迟。
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
日内区间
当前US$8.965
52周区间
当前US$8.965
盘中时间采用ET。市场数据可能有所延迟。
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the TearCare System, a wearable eyelid technology employed by ophthalmologists and optometrists for managing dry eye disease (DED). The company makes its products available across the United States, reaching hospitals, medical centers, and eye care professionals through its direct sales force and distribution partners. Founded in 2010, Sight Sciences' corporate operations are based in Menlo Park, California.
日内区间
当前US$8.965
52周区间
当前US$8.965
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 7736.3万 USD | 7986.6万 USD | 8105.6万 USD | 7133.1万 USD | 4895.6万 USD |
| 销货成本 | 1069.7万 USD | 1158.1万 USD | 1188.1万 USD | 1236.1万 USD | 861万 USD |
| 毛利 | 6666.6万 USD | 6828.5万 USD | 6917.5万 USD | 5897万 USD | 4034.6万 USD |
| 研究与开发 | 1460.6万 USD | 1799.1万 USD | 1755.6万 USD | 2285.9万 USD | 1563.4万 USD |
| 销售、一般及管理费用 | 8915.9万 USD | 1.01亿 USD | 1.09亿 USD | 1.2亿 USD | 7619万 USD |
| 营业费用 | 1.04亿 USD | 1.19亿 USD | 1.26亿 USD | 1.43亿 USD | 9182.4万 USD |
| 利息收入 | 397.3万 USD | — | — | — | — |
| 利息支出 | 514.2万 USD | 466.2万 USD | 540.8万 USD | 446.6万 USD | 436.6万 USD |
| 折旧和摊销 | 48.7万 USD | 71.2万 USD | 61.4万 USD | 71万 USD | 63.2万 USD |
| 营业利润 | −3709.9万 USD | −5053.2万 USD | −5727.4万 USD | −8395.4万 USD | −5147.8万 USD |
| 净利润 | −3842.6万 USD | −5150.7万 USD | −5554.7万 USD | −8624.2万 USD | −6296万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$7.00
下跌空间 21.92%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI971.04万0.00%2.3万亿 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM927.82万0.01%787.4亿 USD0.19%US$277.88-0.38%
Vanguard Extended Market ETFVXF347.03万0.00%954亿 USD0.05%US$233.52-0.63%
iShares Russell 2000 Growth ETFIWO316.38万0.02%139.17亿 USD0.24%US$353.71-0.86%
Vanguard Russell 2000 ETFVTWO191.81万0.01%180亿 USD0.06%US$112.27-0.35%
Schwab U.S. Small-Cap ETFSCHA176.08万0.01%218.24亿 USD0.03%US$32.66-0.40%
Invesco Dorsey Wright SmallCap Momentum ETFDWAS170.59万0.43%3.99亿 USD0.60%US$106.07-1.10%
Dimensional - US Small Cap ETFDFAS122.71万0.00%338.69亿 USD0.31%US$78.17-0.23%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAInvesco Dorsey Wright SmallCap Momentum ETFDWASDimensional - US Small Cap ETFDFASAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
